ICON (ICLR) Reaches New 12-Month High and Low at $127.72

ICON plc (NASDAQ:ICLR) hit a new 52-week high and low on Tuesday . The stock traded as low as $127.72 and last traded at $126.99, with a volume of 1215 shares traded. The stock had previously closed at $126.49.

Several brokerages have recently weighed in on ICLR. BidaskClub raised shares of ICON from a “hold” rating to a “buy” rating in a research report on Wednesday, March 28th. Zacks Investment Research raised shares of ICON from a “sell” rating to a “hold” rating in a research report on Tuesday, May 8th. ValuEngine raised shares of ICON from a “hold” rating to a “buy” rating in a research report on Tuesday, February 13th. Finally, Credit Suisse Group raised shares of ICON to a “buy” rating and set a $131.00 price target for the company in a research report on Friday, February 16th. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. ICON currently has a consensus rating of “Buy” and a consensus price target of $126.18.

The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.85 and a current ratio of 1.85. The stock has a market cap of $6.86 billion, a P/E ratio of 23.04, a P/E/G ratio of 1.99 and a beta of 0.43.

ICON (NASDAQ:ICLR) last released its quarterly earnings data on Thursday, May 3rd. The medical research company reported $1.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.01. ICON had a return on equity of 26.56% and a net margin of 14.80%. The company had revenue of $620.13 million for the quarter, compared to the consensus estimate of $562.61 million. During the same quarter last year, the business posted $1.29 EPS. ICON’s revenue for the quarter was up 43.6% on a year-over-year basis. analysts anticipate that ICON plc will post 6.04 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently made changes to their positions in ICLR. Financial Gravity Companies Inc. acquired a new position in ICON during the 4th quarter worth about $144,000. Financial Gravity Wealth Inc. acquired a new position in ICON during the 1st quarter worth about $179,000. C M Bidwell & Associates Ltd. acquired a new position in ICON during the 4th quarter worth about $196,000. Advisor Partners LLC acquired a new position in ICON during the 4th quarter worth about $201,000. Finally, Dean Capital Investments Management LLC acquired a new position in ICON during the 4th quarter worth about $203,000. 89.28% of the stock is currently owned by hedge funds and other institutional investors.

About ICON

ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Receive News & Ratings for ICON Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply